See more : Pulsar Group plc (PULS.L) Income Statement Analysis – Financial Results
Complete financial analysis of China National Accord Medicines Corporation Ltd. (000028.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China National Accord Medicines Corporation Ltd., a leading company in the Medical – Distribution industry within the Healthcare sector.
You may be interested
- Global Partner Acquisition Corp II (GPACW) Income Statement Analysis – Financial Results
- Caterpillar Inc. (CATR.PA) Income Statement Analysis – Financial Results
- Chongqing Sifang New Material Co., Ltd. (605122.SS) Income Statement Analysis – Financial Results
- Xior Student Housing NV (0RD8.L) Income Statement Analysis – Financial Results
- Agarwal Industrial Corporation Limited (AGARIND.BO) Income Statement Analysis – Financial Results
China National Accord Medicines Corporation Ltd. (000028.SZ)
About China National Accord Medicines Corporation Ltd.
China National Accord Medicines Corporation Ltd. engages in the distribution of medicine and pharmaceutical products. The company sells Chinese traditional, bio-chemical, biological, and diagnosis medicines, as well as antibiotics; chemical preparations; food products; chemical products; and various commodities. It also engages in the sale of medical apparatus and instruments; provision of freight transportation, storage, loading and unloading, and professional consultation services; provision of glass wares, cosmetics, and daily merchandise, as well as goods agency services; import and export of technology; leasing of house properties; and wholesale and retail of health products. As of December 31, 2021, the company operated a network of 8,798 drugstores, including 7,257 directly owned stores and 1,541 franchised stores covering 20 provinces, autonomous regions, and municipalities in China. The company was founded in 2004 and is based in Shenzhen, China. China National Accord Medicines Corporation Ltd. is a subsidiary of Sinopharm Group Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 75.48B | 73.44B | 68.36B | 59.65B | 52.05B | 43.12B | 41.26B | 41.25B | 25.99B | 23.95B | 21.20B | 18.01B | 15.13B | 13.06B | 10.95B | 8.36B | 6.88B | 5.67B | 1.64B | 1.58B | 1.78B | 1.87B | 1.67B | 107.90M | 90.19M | 88.44M | 84.62M | 151.69M | 161.20M | 128.90M | 119.46M | 84.52M | 62.39M |
| Cost of Revenue | 66.47B | 64.52B | 60.34B | 52.59B | 46.29B | 38.02B | 36.82B | 36.65B | 23.97B | 22.00B | 19.44B | 16.41B | 13.80B | 11.93B | 10.02B | 7.63B | 6.17B | 5.09B | 1.26B | 1.20B | 1.35B | 1.46B | 1.21B | 69.44M | 55.26M | 62.56M | 57.38M | 89.11M | 103.53M | 74.34M | 55.53M | 42.26M | 0.00 |
| Gross Profit | 9.01B | 8.93B | 8.02B | 7.06B | 5.75B | 5.10B | 4.44B | 4.60B | 2.02B | 1.95B | 1.76B | 1.60B | 1.33B | 1.14B | 928.65M | 732.54M | 707.10M | 581.63M | 373.15M | 373.25M | 431.69M | 413.41M | 462.34M | 38.46M | 34.93M | 25.88M | 27.24M | 62.58M | 57.67M | 54.56M | 63.93M | 42.26M | 62.39M |
| Gross Profit Ratio | 11.93% | 12.15% | 11.73% | 11.83% | 11.05% | 11.82% | 10.77% | 11.15% | 7.78% | 8.15% | 8.32% | 8.90% | 8.82% | 8.72% | 8.48% | 8.76% | 10.28% | 10.26% | 22.81% | 23.68% | 24.24% | 22.11% | 27.71% | 35.64% | 38.73% | 29.26% | 32.19% | 41.25% | 35.77% | 42.33% | 53.52% | 50.00% | 100.00% |
| Research & Development | 26.82M | 9.07M | 7.74M | 0.00 | 0.00 | 0.00 | 0.00 | 43.73M | 73.15M | 81.22M | 79.43M | 79.36M | 63.52M | 52.83M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 215.29M | 197.70M | 183.42M | 190.62M | 159.32M | 145.39M | 133.85M | 169.94M | 77.82M | 92.53M | 82.76M | 70.14M | 81.13M | 66.46M | 245.89M | 204.92M | 188.97M | 180.86M | 105.63M | 69.85M | 77.95M | 99.35M | 96.21M | 40.91M | 29.39M | 38.18M | 32.88M | 27.67M | 22.99M | 17.97M | 12.65M | 6.63M | 0.00 |
| Selling & Marketing | 2.59B | 5.27B | 4.75B | 3.95B | 3.07B | 2.77B | 2.31B | 2.21B | 533.79M | 522.38M | 486.39M | 448.60M | 429.90M | 430.59M | 384.24M | 298.33M | 331.53M | 302.04M | 248.32M | 294.61M | 334.48M | 309.46M | 326.13M | 19.27M | 18.22M | 20.85M | 21.34M | 4.59M | 6.62M | 7.94M | 3.84M | 3.33M | 0.00 |
| SG&A | 6.48B | 5.47B | 4.94B | 4.14B | 3.23B | 2.92B | 2.44B | 2.38B | 611.62M | 614.91M | 569.15M | 518.73M | 511.03M | 497.05M | 630.13M | 503.24M | 520.50M | 482.90M | 353.96M | 364.46M | 412.43M | 408.81M | 422.35M | 60.18M | 47.61M | 59.03M | 54.22M | 32.25M | 29.61M | 25.91M | 16.49M | 9.96M | 0.00 |
| Other Expenses | 6.51M | 1.03B | 928.27M | 891.45M | 763.08M | 7.95M | 2.14M | 53.43M | 55.17M | 48.34M | 13.74M | 40.96M | 20.65M | 17.46M | 9.38M | 19.69M | 22.36M | 37.25M | 23.04M | 22.80M | 19.23M | 16.72M | 28.25M | 22.97M | 44.35M | 49.65M | 1.11M | 12.27M | 3.03M | 12.57M | 2.26M | -1.12M | 0.00 |
| Operating Expenses | 6.58B | 6.51B | 5.86B | 5.03B | 3.99B | 3.64B | 3.14B | 3.18B | 1.04B | 1.04B | 954.45M | 887.00M | 818.19M | 751.38M | 645.72M | 514.37M | 532.75M | 491.12M | 356.12M | 366.92M | 415.07M | 411.82M | 425.03M | 60.25M | 47.70M | 59.14M | 54.28M | 32.30M | 30.04M | 26.14M | 25.62M | 15.73M | 0.00 |
| Cost & Expenses | 73.01B | 71.03B | 66.20B | 57.63B | 50.28B | 41.66B | 39.96B | 39.83B | 25.02B | 23.05B | 20.39B | 17.30B | 14.61B | 12.68B | 10.67B | 8.14B | 6.70B | 5.58B | 1.62B | 1.57B | 1.76B | 1.87B | 1.63B | 129.69M | 102.96M | 121.70M | 111.65M | 121.41M | 133.57M | 100.47M | 25.62M | 57.99M | 0.00 |
| Interest Income | 77.55M | 72.94M | 74.30M | 136.46M | 139.84M | 81.12M | 35.01M | 30.14M | 5.64M | 9.12M | 5.10M | 4.00M | 6.35M | 4.09M | 3.59M | 2.95M | 2.29M | 4.46M | 2.04M | 3.95M | 3.51M | 2.79M | 3.51M | 1.73M | -0.02 | -0.01 | -0.85 | -0.96 | -0.95 | 0.00 | -0.99 | -0.79 | 0.00 |
| Interest Expense | 285.04M | 261.91M | 288.04M | 258.19M | 271.72M | 195.26M | 135.83M | 133.78M | 119.43M | 153.29M | 182.16M | 156.87M | 130.42M | 79.32M | 47.08M | 51.09M | 29.92M | 24.10M | 308.14K | 6.52M | 11.55M | 14.62M | 16.44M | 4.26M | 1.05M | 9.57M | 4.17M | 1.31M | 579.99K | 0.00 | 2.23M | 732.43K | 0.00 |
| Depreciation & Amortization | 1.59B | 1.49B | 1.43B | 1.19B | 927.10M | 206.11M | 179.81M | 219.72M | 106.24M | 104.78M | 99.18M | 94.70M | 90.14M | 83.02M | 67.04M | 43.69M | 32.81M | 30.94M | 19.30M | 21.39M | 21.04M | 17.54M | 16.34M | 15.26M | 16.78M | 14.33M | 980.84K | -7.55M | 1.86M | -5.82M | -63.97M | -143.40K | 0.00 |
| EBITDA | 4.03B | 3.76B | 3.40B | 3.30B | 2.76B | 1.80B | 1.56B | 1.90B | 1.22B | 1.09B | 940.44M | 821.19M | 607.36M | 478.87M | 361.28M | 303.48M | 253.78M | 115.42M | 61.23M | 53.57M | 44.33M | 34.24M | 64.38M | 10.54M | 4.67M | -15.75M | -30.03M | 30.28M | 27.63M | 28.42M | -25.62M | 26.53M | 62.39M |
| EBITDA Ratio | 5.34% | 5.62% | 5.65% | 5.99% | 5.88% | 4.61% | 4.14% | 4.59% | 4.71% | 4.77% | 4.63% | 4.91% | 4.29% | 3.92% | 3.54% | 3.54% | 3.83% | 2.82% | 3.74% | 3.40% | 2.52% | 1.83% | 4.73% | 15.33% | 5.18% | -21.42% | -31.95% | 19.96% | 17.14% | 22.05% | -21.45% | 31.39% | 100.00% |
| Operating Income | 2.47B | 2.31B | 1.95B | 2.16B | 1.84B | 1.67B | 1.46B | 1.55B | 906.59M | 781.49M | 645.01M | 571.46M | 387.07M | 322.90M | 251.94M | 184.30M | 169.33M | 101.42M | 41.69M | 21.43M | 4.76M | -7.60M | 24.67M | -16.93M | 33.45M | 10.25M | -28.02M | 37.82M | 25.77M | 34.25M | 38.35M | 26.67M | 62.39M |
| Operating Income Ratio | 3.27% | 3.14% | 2.86% | 3.63% | 3.53% | 3.87% | 3.55% | 3.75% | 3.49% | 3.26% | 3.04% | 3.17% | 2.56% | 2.47% | 2.30% | 2.20% | 2.46% | 1.79% | 2.55% | 1.36% | 0.27% | -0.41% | 1.48% | -15.69% | 37.08% | 11.59% | -33.11% | 24.94% | 15.99% | 26.57% | 32.10% | 31.56% | 100.00% |
| Total Other Income/Expenses | 5.80M | 13.47M | 22.44M | -6.60M | 21.11M | 7.95M | 2.14M | 42.92M | -94.85M | -2.62M | -112.91M | -91.53M | -117.19M | -65.58M | 9.00M | 3.97M | 21.72M | 3.25M | 42.25M | 4.23M | 6.92M | 9.68M | 6.93M | 7.96M | -5.89M | -1.37M | -603.50K | 10.45M | 1.90M | 8.10M | 0.00 | -2.00M | -45.74M |
| Income Before Tax | 2.47B | 2.31B | 1.97B | 2.16B | 1.86B | 1.68B | 1.47B | 1.60B | 961.31M | 829.28M | 659.10M | 603.32M | 409.28M | 339.81M | 260.79M | 203.50M | 191.05M | 104.68M | 41.62M | 25.66M | 12.23M | 2.08M | 46.12M | -2.98M | 27.56M | 8.99M | -29.90M | 48.28M | 27.67M | 42.34M | 38.35M | 24.68M | 16.64M |
| Income Before Tax Ratio | 3.28% | 3.15% | 2.89% | 3.62% | 3.57% | 3.89% | 3.55% | 3.88% | 3.70% | 3.46% | 3.11% | 3.35% | 2.71% | 2.60% | 2.38% | 2.43% | 2.78% | 1.85% | 2.54% | 1.63% | 0.69% | 0.11% | 2.76% | -2.76% | 30.56% | 10.16% | -35.34% | 31.83% | 17.16% | 32.85% | 32.10% | 29.20% | 26.67% |
| Income Tax Expense | 514.74M | 539.33M | 447.21M | 435.94M | 372.44M | 330.50M | 309.29M | 318.38M | 173.96M | 159.44M | 124.88M | 119.63M | 81.47M | 75.59M | 62.53M | 41.04M | 52.33M | 29.90M | 6.10M | 6.94M | 5.47M | 8.01M | 11.51M | 602.76K | 1.93M | -56.05M | -4.15M | 8.26M | 4.58M | 6.32M | 5.68M | 3.99M | 2.68M |
| Net Income | 1.60B | 1.49B | 1.34B | 1.40B | 1.27B | 1.21B | 1.06B | 1.19B | 761.31M | 652.50M | 520.49M | 475.79M | 330.31M | 261.12M | 192.71M | 154.81M | 124.91M | 72.56M | 35.77M | 27.25M | 15.19M | 4.92M | 36.52M | -1.78M | 20.59M | 14.12M | -29.73M | 40.54M | 23.33M | 36.02M | 32.66M | 20.68M | 13.96M |
| Net Income Ratio | 2.12% | 2.02% | 1.96% | 2.35% | 2.44% | 2.81% | 2.56% | 2.88% | 2.93% | 2.72% | 2.46% | 2.64% | 2.18% | 2.00% | 1.76% | 1.85% | 1.82% | 1.28% | 2.19% | 1.73% | 0.85% | 0.26% | 2.19% | -1.65% | 22.83% | 15.96% | -35.13% | 26.73% | 14.47% | 27.95% | 27.34% | 24.47% | 22.37% |
| EPS | 2.87 | 2.67 | 2.40 | 2.52 | 2.28 | 2.18 | 1.90 | 2.15 | 1.68 | 1.46 | 1.39 | 1.27 | 0.88 | 0.70 | 0.52 | 0.42 | 0.33 | 0.21 | 0.10 | 0.07 | 0.04 | 0.01 | 0.06 | -0.01 | 0.06 | 0.01 | -0.10 | 0.11 | 0.06 | 0.10 | 0.09 | 0.07 | 0.05 |
| EPS Diluted | 2.87 | 2.67 | 2.40 | 2.52 | 2.28 | 2.18 | 1.90 | 2.15 | 1.68 | 1.46 | 1.39 | 1.27 | 0.88 | 0.70 | 0.52 | 0.42 | 0.33 | 0.21 | 0.10 | 0.07 | 0.04 | 0.01 | 0.06 | -0.01 | 0.06 | 0.01 | -0.10 | 0.11 | 0.06 | 0.10 | 0.09 | 0.07 | 0.05 |
| Weighted Avg Shares Out | 557.23M | 556.57M | 556.57M | 556.57M | 556.57M | 556.17M | 556.57M | 550.89M | 549.92M | 446.45M | 373.83M | 374.87M | 374.40M | 373.02M | 374.22M | 377.68M | 374.17M | 375.15M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M |
| Weighted Avg Shares Out (Dil) | 556.57M | 556.57M | 556.57M | 556.57M | 556.57M | 556.17M | 556.73M | 550.89M | 550.64M | 446.45M | 373.83M | 374.87M | 374.40M | 373.02M | 374.22M | 377.68M | 374.17M | 375.15M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M | 287.82M |
No news found for: 000028.SZ
Source: https://incomestatements.info
Category: Stock Reports